European Pharmaceutical Review

FEBRUARY 22, 2023

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. the enteric coating and the capsule dissolve.

Immunization 105

Immunization Packaging Labelling FDA 105

Pharmacy Times

JULY 7, 2025

Takeda will discontinue Gammagard S/D by December 2027, transitioning to the new low IgA formulation. Pharmacists are essential in evaluating patient suitability for Gammagard Liquid ERC, considering IgA levels and potential hypersensitivity reactions.

FDA 97

FDA Immunization Compounding Pharmacies Compounding 97

Pharmaceutical Technology

JULY 1, 2025

The US Food and Drug Administration (FDA) has approved Takeda’s new immunoglobulin (IG) therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat primary immunodeficiency (PI) in individuals aged two years and above. Credit: HenadziPechan/Shutterstock. Don’t let policy changes catch you off guard.

FDA 52

FDA Packaging Communication Hospitals 52

Roots Analysis

JANUARY 27, 2025

Moreover, protein-based drugs are also well tolerated inside the body, thereby reducing the chances of causing any immune response in the body. Currently, antibodies segment is likely to occupy the largest share in the overall market.

Hospitals 40

Hospitals Packaging Compounding Immunization 40

ISPE

MARCH 8, 2023

The cases covered the same types of contaminants and impurities noted in Table 1: microbial contaminants, process-related im-purities, metal contaminants, packaging-related contaminants, drug cross-contamination, and an “unknown” category encompassing other contaminants associated with the manufacturing process, including those from cell culturing.

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52

BuzzRx

AUGUST 30, 2022

This law includes a broad package of provisions concerning healthcare, taxes, and climate change. In 2018-2019, 25 states did not cover all the vaccines recommended by the Advisory Committee on Immunization Practices (ACIP). The Inflation Reduction Act of 2022 was signed into law by President Joe Biden on August 16, 2022.

Vaccines 52

Vaccines Insurance Packaging Immunization 52